In focus · trending topic

#aids

24 stories · following the connections

Immune Therapeutics Signs Memorandum of Understanding for Distribution of Lodonal™ in Côte d’Ivoire and acquires COPP for Côte d’Ivoire; Company Plans for Approval of Lodonal in Côte d’Ivoire in 2017

By Nasdaq OMXMay 31, 2017, 1:33 PM UTC

CORRECTING and REPLACING: Immune Therapeutics, Inc.

By Nasdaq OMXMay 22, 2017, 1:25 PM UTC

CORRECTING and REPLACING: Immune Therapeutics, Inc.

By Nasdaq OMXMay 22, 2017, 1:25 PM UTC

Immune Therapeutics Announces NAFDAC Approval of Lodonal™ for the Treatment of HIV in Nigeria

By Nasdaq OMXMay 22, 2017, 12:42 PM UTC

Immune Therapeutics, Inc. Announces Expansion of Patent Portfolio

By Nasdaq OMXMar 30, 2017, 1:46 PM UTC

Immune Therapeutics Clears Critical Certification Milestone

By Nasdaq OMXFeb 2, 2017, 2:40 PM UTC

UPDATE -- Immune Therapeutics Issues Special Letter to Shareholders

By Nasdaq OMXJan 30, 2017, 3:49 PM UTC

Immune Therapeutics Issues Special Letter to Shareholders

By Nasdaq OMXJan 30, 2017, 1:40 PM UTC